The Journal of Practical Medicine >
The new role of lifestyle interventions in the clinical prevention and treatment of type 2 diabetes
Received date: 2025-07-25
Online published: 2025-09-05
The number of patients with type 2 diabetes （T2DM） is rapidly increasing with the annual rise in obesity rates， placing a serious burden on healthcare systems worldwide. In recent years， the potential of lifestyle interventions（LSI） to prevent and treat T2DM through effective weight loss has been recognized， and their importance in the clinical prevention and treatment of T2DM has grown. However， there are still many challenges to be overcome in order to achieve effective LSI prevention and control of T2DM， from theory to clinical application， including a lack of professional guidance， poor patient compliance， and weight regain. Nevertheless， given the outstanding results of numerous evidence-based medical studies on lifestyle interventions in the prevention and treatment of T2DM， as well as their theoretical feasibility，the shift from a “drug-centric” to an “LSI-centric” bringing new hope and new challenges to the clinical prevention and treatment of T2DM.
Key words： lifestyle Intervention; Type 2 diabetes; weight loss
Xiaoyu NING , Xiaoyan CHEN . The new role of lifestyle interventions in the clinical prevention and treatment of type 2 diabetes[J]. The Journal of Practical Medicine, 2025 , 41(17) : 2611 -2616 . DOI: 10.3969/j.issn.1006-5725.2025.17.001
| [1] | The Lancet. Diabetes： a defining disease of the 21st century［J］. Lancet， 2023， 401（10394）：2087. doi:10.1016/s0140-6736(23)01296-5 |
| [2] | LAURYN STAFFORD， LIANE ONG. Global diabetes cases on pace to soar to 1.3 billion people in the next 3 decades， new study finds ［M］. 2023-07-19. . doi:10.64628/aai.3qd6dygme |
| [3] | CURRENTI W， LOSAVIO F， QUIETE S， et al. Comparative Evaluation of a Low-Carbohydrate Diet and a Mediterranean Diet in Overweight/Obese Patients with Type 2 Diabetes Mellitus： A 16-Week Intervention Study ［J］. Nutrients， 2023， 16（1）：95. doi:10.3390/nu16010095 |
| [4] | ROSENFELD R M， GREGA M L， KARLSEN M C， et al. Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults： A Clinical Practice Guideline From the American College of Lifestyle Medicine ［J］， Am J Lifestyle Med， 2025， 19（2 ）： 10S-131S. doi:10.1177/15598276251325441 |
| [5] | KLEIN S， GASTALDELLI A， YKI-J?RVINEN H， et al. Why does obesity cause diabetes？ ［J］. Cell Metab， 2022， 34（1）： 11-20. doi:10.1016/j.cmet.2021.12.012 |
| [6] | LU X， XIE Q， PAN X， et al. Type 2 diabetes mellitus in adults： Pathogenesis， prevention and therapy ［J］. Signal Transduct Target Ther， 2024， 9（1）： 262. doi:10.1038/s41392-024-01951-9 |
| [7] | LINGVAY I， SUMITHRAN P， COHEN R V， et al. Obesity management as a primary treatment goal for type 2 diabetes： Time to reframe the conversation ［J］. Lancet， 2022， 399（10322）： 394-405. doi:10.1016/s0140-6736(21)01919-x |
| [8] | VODOVOTZ Y， BARNARD N， HU F B， et al. Prioritized Research for the Prevention， Treatment， and Reversal of Chronic Disease： Recommendations From the Lifestyle Medicine Research Summit ［J］. Front Med （Lausanne）， 2020， 7： 585744. doi:10.3389/fmed.2020.585744 |
| [9] | KNOWLER W C， FOWLER S E， HAMMAN R F， et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study ［J］. Lancet， 2009， 374（9702）： 1677-1686. doi:10.1016/s0140-6736(09)61457-4 |
| [10] | LI G， ZHANG P， WANG J， et al. Cardiovascular mortality， all-cause mortality， and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study： A 23-year follow-up study ［J］. Lancet Diabetes Endocrinol， 2014， 2（6）： 474-480. doi:10.1016/s2213-8587(14)70057-9 |
| [11] | GOYAL MEHRA C， RAYMOND A M， PRABHU R. A personalized multi-interventional approach focusing on customized nutrition， progressive fitness， and lifestyle modification resulted in the reduction of HbA1c， fasting blood sugar and weight in type 2 diabetes： A retrospective study ［J］. BMC Endocr Disord， 2022， 22（1）： 290. doi:10.1186/s12902-022-01212-2 |
| [12] | CHAI X， WANG Y， YIN X， et al. Effects of lifestyle interventions on the prevention of type 2 diabetes and reversion to normoglycemia by prediabetes phenotype： A systematic review and meta-analysis of randomized controlled trials ［J］. Diabetes Metab Syndr， 2025， 19（1）： 103184. doi:10.1016/j.dsx.2025.103184 |
| [13] | LU Q， CHEN J， LI R， et al. Healthy lifestyle， plasma metabolites， and risk of cardiovascular disease among individuals with diabetes ［J］. Atherosclerosis， 2023， 367： 48-55. doi:10.1016/j.atherosclerosis.2022.12.008 |
| [14] | TRIPATHI P， SHARMA B， KADAM N， et al. Improvement in symptoms of anxiety and depression in individuals with type 2 diabetes： Retrospective analysis of an intensive lifestyle modification program ［J］. BMC Psychiatry， 2024， 24（1）： 714. doi:10.1186/s12888-024-06130-2 |
| [15] | JAMES N， GIBBONS K， AGBOYIBOR K， et al. Tackling the （un）affordability of medicines for cardiometabolic risk factors worldwide： A call to action［J］. BMJ Glob Health， 2025， 10（7）： e019824. doi:10.1136/bmjgh-2025-019824 |
| [16] | BARTHILD D， LI J， BASU A. Patient out-of-pocket costs for type 2 diabetes medications when aging into Medicare［J］. JAMA Netw Open， 2024， 7（7）： e2420724. doi:10.1001/jamanetworkopen.2024.20724 |
| [17] | ALFAIFI A. Association between non-pharmacological therapy and healthcare use and expenditure of patients with diabetes mellitus［J］. Saudi Pharm J， 2023， 31（8）： 101685. doi:10.1016/j.jsps.2023.06.018 |
| [18] | EZURA M， SAITO S， ISHIZAWA M， et al. Estimation of the effects and costs of lifestyle intervention and treatment with voglibose in the Japanese prediabetic population： A cost-effectiveness analysis［J］. Value Health Reg Issues， 2025， 47： 101098. doi:10.1016/j.vhri.2025.101098 |
| [19] | HESKETH K， LOW J， ANDREWS R， et al. Mobile health biometrics to enhance exercise and physical activity adherence in type 2 diabetes （MOTIVATE-T2DM）： A decentralised feasibility randomised controlled trial delivered across the UK and Canada［J］. BMJ Open， 2025， 15（3）： e092260. doi:10.1136/bmjopen-2024-092260 |
| [20] | MA J， WAN X， WU B. The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting［J］. J Diabetes Res， 2020， 2020： 7410797. doi:10.1155/2020/7410797 |
| [21] | 顾东风， 翁建平， 鲁向锋. 中国健康生活方式预防心血管代谢疾病指南［J］. 中国循环杂志， 2020， 35（3）： 209-230. |
| [22] | DIABETES PREVENTION PROGRAM RESEARCH G. The Diabetes Prevention Program （DPP）： Description of lifestyle intervention［J］. Diabetes Care， 2002， 25（12）： 2165-2171. doi:10.2337/diacare.25.12.2165 |
| [23] | ZHANG P， ATKINSON K M， BRAY G A， et al. Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes： Results From the Action for Health in Diabetes （Look AHEAD） Study［J］. Diabetes Care， 2021， 44（1）： 67-74. |
| [24] | LINDSTR?M J， PELTONEN M， ERIKSSON J G， et al. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study［J］. Diabetes Care， 2008， 31（5）： 857-862. doi:10.2337/dc07-2162 |
| [25] | HU G， LIU H， LENG J， et al. Effects of a Lifestyle Intervention in Young Women with GDM and Subsequent Diabetes［J］. Nutrients， 2022， 14（24）：5232. doi:10.3390/nu14245232 |
| [26] | PE?A A， OLSON M L， HOOKER E， et al. Effects of a Diabetes Prevention Program on Type 2 Diabetes Risk Factors and Quality of Life Among Latino Youths With Prediabetes： A Randomized Clinical Trial［J］. JAMA Netw Open， 2022， 5（9）： e2231196. doi:10.1001/jamanetworkopen.2022.31196 |
| [27] | DAVIES M J， D'ALESSIO D A， FRADKIN J， et al. Management of Hyperglycemia in Type 2 Diabetes， 2018. A Consensus Report by the American Diabetes Association （ADA） and the European Association for the Study of Diabetes （EASD）［J］. Diabetes Care， 2018， 41（12）： 2669-2701. doi:10.2337/dci18-0033 |
| [28] | 中华医学会内分泌学分会， 中华医学会糖尿病学分会， 中国医师协会内分泌代谢科医师分会，等. 中国成人糖尿病前期干预的专家共识（2023版） ［J］. 中华糖尿病杂志， 2023， 15（6）： 484-494. |
| [29] | SPURR S， BALLY J， NALWOOGA N. Honoring the voices of families： An interpretive description of parents' understandings of， and insights into preventing type 2 diabetes in adolescents［J］. BMC Pediatr， 2022， 22（1）： 458. doi:10.1186/s12887-022-03487-9 |
| [30] | AL-BADRI M， KILROY C L， SHAHAR J I， et al. In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity［J］. Ther Adv Endocrinol Metab， 2022， 13： 20420188221093220. doi:10.1177/20420188221093220 |
| [31] | HAMDY O， CARVER C. The Why WAIT program： improving clinical outcomes through weight management in type 2 diabetes［J］. Curr Diab Rep， 2008， 8（5）： 413-420. doi:10.1007/s11892-008-0071-5 |
| [32] | RUIZ-LEON A M， CASAS R， CASTRO-BARQUERO S， et al. Efficacy of a Mobile Health-Based Behavioral Treatment for Lifestyle Modification in Type 2 Diabetes Self-Management： Greenhabit Randomized Controlled Trial［J］. J Med Internet Res， 2025， 27： e58319. doi:10.2196/58319 |
| [33] | KO J H， MOON S J， AJJAN R A， et al. Workplace-based continuous glucose monitoring with structured education for pre-diabetes and type 2 diabetes： A prospective community cohort study［J］. Diabetes Obes Metab， 2025， 27（6）： 2996-3005. doi:10.1111/dom.16304 |
| [34] | GREGG E W， CHEN H， WAGENKNECHT L E， et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes［J］. JAMA， 2012， 308（23）： 2489-2496. doi:10.1001/jama.2012.67929 |
| [35] | KNOWLER W C， BARRETT-CONNOR E， FOWLER S E， et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin［J］. N Engl J Med， 2002， 346（6）： 393-403. doi:10.1056/nejmoa012512 |
| [36] | TUOMILEHTO J， LINDSTR?M J， ERIKSSON J G， et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance ［J］. N Engl J Med， 2001， 344（18）： 1343-1350. doi:10.1056/nejm200105033441801 |
| [37] | WHO. Diabetes ［M］. 2024-11-14. |
| [38] | American Diabetes Association Professional Practice Committee. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes： Standards of Care in Diabetes-2025［J］. Diabetes Care， 2025， 48（1 ）： S167-s180. doi:10.2337/dc22-s008 |
| [39] | 中华医学会糖尿病学分会. 中国糖尿病防治指南（2024版）［J］. 中华糖尿病杂志， 2025， 17（1）： 16-139. |
| [40] | BANCKS M P， CHEN H， BALASUBRAMANYAM A， et al. Type 2 Diabetes Subgroups， Risk for Complications， and Differential Effects Due to an Intensive Lifestyle Intervention ［J］. Diabetes Care， 2021， 44（5）： 1203-1210. doi:10.2337/dc20-2372 |
| [41] | WING R R， BOLIN P， BRANCATI F L， et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes ［J］. N Engl J Med， 2013， 369（2）： 145-154. doi:10.1056/nejmoa1212914 |
| [42] | TAYLOR R， AL-MRABEH A， SATTAR N. Understanding the mechanisms of reversal of type 2 diabetes ［J］. Lancet Diabetes Endocrinol， 2019， 7（9）： 726-736. doi:10.1016/s2213-8587(19)30076-2 |
/
| 〈 |
|
〉 |